Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries’ profits for the first nine months of fiscal year 2016/2017 increased by 52.7% to EGP 72.96 million, compared to EGP 47.79 million for the same period of FY15/16.
Revenues for the first nine months of FY16/17 rose to EGP 421.35 million from EGP 331.3 million for the same period last year.
